Document is current
Any future updates will be listed below
-
Authors
James, Spencer L.
Hede, Shalini
Ewing-Crawford, Altovise T.
Bhagat, Ruma
Richie, Nicole
D’Rozario, Mitchell
Theodore, Pierre
Lavery, Bea
Bentouati, Sarah
Oron, Assaf P.
Gillespie, Catherine W.
Ryals, Cleo A.
Bair-Merritt, Megan H.
Chesley, Johanna
Jiagge, Evelyn
Jolain, Bruno
-
Funding
Funding for this research was provided by:
Genentech
F. Hoffmann-La Roche
- License Information
-
More Information
Article History
Received: 13 February 2025
Accepted: 10 June 2025
First Online: 1 August 2025
Declarations
:
: All authors have completed the ICMJE uniform disclosure form at and declare: Shalini Hede: employee of Roche, Spencer L James: former employee of Roche, Altovise T Ewing-Crawford: nothing to declare, Ruma Bhagat: nothing to declare, Nicole Richie: nothing to declare, Mitchell D’Rozario: owns stock in Roche, Pierre Theodore: employee of Roche/Genentech Inc, and owns stock in Roche, Bea Lavery: employee of Genentech Inc., Sarah Bentouati: nothing to declare, Assaf Oron: nothing to declare, Kate W Gillespie: employee of the University of Washington. No payments were made to myself or my institution for the present manuscript, Cleo A Ryals: employee of Flatiron, a member of the Roche group and owns Roche stock, Megan Bair-Merritt: nothing to declare, Johanna Chesley: nothing to declare, Evelyn Jiagge: received the Genentech Health Equity Innovation Grant and Pfizer Global Medical Grant; has received other grants from Pfizer, Bruno Jolain: employee of and owns stock in Roche.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.
